NEWBOLD SURGERY — All Prescriptions & Medications
Practice Code: C81015 | CHESTERFIELD, S41 8DU
Over the last 12 months, NEWBOLD SURGERY prescribed 249,952 items across 615 different medications at a total cost of £2,125,977 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Dronedarone hydrochloride | 10 | 1,120 | £1.3K | -30.8% ▼ |
| Midazolam hydrochloride | 10 | 42 | £959 | -30.6% ▼ |
| Calcium acetate | 10 | 1,248 | £129 | -46.0% ▼ |
| Ketotifen fumarate | 10 | 300 | £66 | +7.5% ▲ |
| Dexamethasone sodium metasulphobenzoate | 10 | 80 | £71 | +34.5% ▲ |
| Cocois | 10 | 1,100 | £171 | -27.2% ▼ |
| Amorolfine hydrochloride | 10 | 50 | £64 | -56.7% ▼ |
| 10 | 1,000 | £45 | -45.4% ▼ | |
| 10 | 17 | £17 | -67.9% ▼ | |
| 10 | 29 | £61 | -58.7% ▼ | |
| 10 | 29 | £346 | -21.4% ▼ | |
| 10 | 31 | £674 | -27.6% ▼ | |
| 10 | 50 | £139 | +38.0% ▲ | |
| 10 | 400 | £1.4K | -9.4% ▼ | |
| 10 | 1,050 | £98 | -2.2% ▼ | |
| 10 | 240 | £334 | -21.5% ▼ | |
| Glyceryl trinitrate | 11 | 330 | £411 | -17.2% ▼ |
| Cefradine | 11 | 480 | £328 | +16.2% ▲ |
| Soluble insulin (Neutral insulin) | 11 | 86 | £399 | +14.2% ▲ |
| Deflazacort | 11 | 1,356 | £341 | +24.7% ▲ |
| Trospium chloride | 11 | 364 | £285 | -78.5% ▼ |
| Magnesium citrate | 11 | 632 | £1.1K | +52.1% ▲ |
| Riboflavin | 11 | 1,100 | £2.0K | +19.0% ▲ |
| Meloxicam | 11 | 592 | £16 | -83.4% ▼ |
| 11 | 2,155 | £102 | -56.3% ▼ | |
| 11 | 330 | £617 | -14.0% ▼ | |
| 11 | 330 | £133 | -5.8% ▼ | |
| 11 | 3,481 | £171 | +35.8% ▲ | |
| 11 | 130 | £652 | +16.5% ▲ | |
| 11 | 290 | £1.8K | -4.4% ▼ | |
| Balsalazide sodium | 12 | 3,120 | £694 | -19.4% ▼ |
| Acrivastine | 12 | 912 | £268 | -2.6% ▼ |
| Mebendazole | 12 | 160 | £15 | +4.8% ▲ |
| Canagliflozin | 12 | 340 | £423 | -91.6% ▼ |
| Goserelin acetate | 12 | 12 | £840 | -72.8% ▼ |
| Ready to serve 1.5 kcal/ml smoothie (0913021) | 12 | 67.2K | £1.7K | +91.9% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 12 | 296.0K | £6.2K | +25.1% ▲ |
| Zinc oxide | 12 | 2,500 | £80 | -40.3% ▼ |
| Eflornithine monohydrate chloride | 12 | 720 | £648 | +70.8% ▲ |
| 12 | 450 | £781 | +0.7% vs avg | |
| 12 | 450 | £2.5K | +90.1% ▲ | |
| 12 | 200 | £20 | -58.6% ▼ | |
| 12 | 26 | £158 | -32.4% ▼ | |
| 12 | 4,920 | £1.7K | +71.0% ▲ | |
| Naloxegol | 13 | 370 | £648 | -5.7% ▼ |
| Chlorothiazide | 13 | 3,950 | £722 | +134.2% ▲ |
| Moxonidine | 13 | 1,120 | £146 | -76.6% ▼ |
| Naftidrofuryl oxalate | 13 | 1,512 | £176 | -60.1% ▼ |
| Aclidinium bromide | 13 | 13 | £402 | -51.0% ▼ |
| Dosulepin hydrochloride | 13 | 364 | £79 | -77.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.